NEO - NeoGenomics Non-GAAP EPS of -$0.05 beats by $0.06 revenue of $146.92M beats by $9.49M
2023-08-08 07:07:29 ET
- NeoGenomics press release ( NASDAQ: NEO ): Q2 Non-GAAP EPS of -$0.05 beats by $0.06 .
- Revenue of $146.92M (+17.5% Y/Y) beats by $9.49M .
- Clinical Services revenue increased 17% to $123M
- Advanced Diagnostics revenue increased 22% to $24M
For further details see:
NeoGenomics Non-GAAP EPS of -$0.05 beats by $0.06, revenue of $146.92M beats by $9.49M